Azilsartan/Amlodipine Besylate

阿齐沙坦/苯磺酸氨氯地平

Report date: 2026/03/16 15:02:30

Base Information

Drug NameAzilsartan/Amlodipine Besylate
Drug Alias NameAmlodipine Besylate/Azilsartan阿齐沙坦苯磺酸氨氯地平阿齐沙坦氨氯地平Azilsartan/Amlodipine Besilate氨氯地平/阿齐沙坦 +[9
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryJapan
Original Approved Date2014/03/24
Country/TerritoryMainland ChinaJapan
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsEssential Hypertension

Other Information

ATC CodeC09D
Related LinksKEGG